Répertoire du corps professoral

Projet TRADI : Trajectoires de soins et d’adhésion aux traitements des personnes ayant un diabète
Programme: Développement de projets de recherche 2022-2023 Chercheur(-euse)s régulier(-ère)s
Organisme(s) subventionnaire(s): CIUSSS-CN VITAM Centre de recherche en santé durable
Type de financement: Subvention
Établissement tête: Université Laval
Du 8 février 2023 au 31 mars 2025

Jihane El Mourad, Doctorat en sciences pharmaceutiques - pharmaco-épidémiologie

Codjo Giraud Ulrich Ekanmian, Doctorat en sciences pharmaceutiques - pharmaco-épidémiologie

Publications des 5 dernières années

Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study Schizophrenia Research, 2024. Dubois, Cerina, Lunghi, Carlotta, Eurich, Dean T., Dyck, Jason R. B., Hyshka, Elaine, Hanlon, John G., Zongo, Arsene. DOI 10.1016/J.SCHRES.2024.01.029

Cluster B personality disorders and psychotropic medications: a focused analysis of trends and patterns across sex and age groups Social Psychiatry and Psychiatric Epidemiology, 2024. Lunghi, Carlotta, Cailhol, Lionel, Massamba, Victoria, Renaud, Suzane, David, Pierre, Sidi, Elhadji A. Laouan, Biskin, Robert, Koch, Marion, Martineau, Cathy, Rahme, Elham, Rochette, Louis, Sirois, Caroline, Villeneuve, Evens, Vincent, Philippe, Lesage, Alain. DOI 10.1007/S00127-024-02768-1

ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study Translational Psychiatry, 2024. Vasiliadis, Helen-Maria, Lunghi, Carlotta, Rahme, Elham, Rochette, Louis, Gignac, Martin, Massamba, Victoria, Diallo, Fatoumata Binta, Fansi, Alvine, Cortese, Samuele, Lesage, Alain. DOI 10.1038/S41398-024-02825-Y

Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016 Frontiers in Pharmacology, 2023. Lunghi, C., Rochette, L., Massamba, V., Tardif, I., Ouali, A., Sirois, C.. DOI 10.3389/fphar.2023.1080073

Medication use in Italian nursing homes: preliminary results from the national monitoring system Frontiers in Pharmacology, 2023. Zito, S., Poluzzi, E., Pierantozzi, A., Onder, G., Da Cas, R., Ippoliti, I., Lunghi, C., Cangini, A., Trotta, F.. DOI 10.3389/FPHAR.2023.1128605

Changes in self-rated physical and mental health and life satisfaction associated with opioid and potentially inappropriate opioid prescribing in primary care older adults Family Practice, 2023. Pitrou, Isabelle, D'Aiuto, Carina, Lunghi, Carlotta, Guenette, Line, Berbiche, Djamal, Bertrand, Karine, Vasiliadis, Helen-Maria. DOI 10.1093/FAMPRA/CMAD050

Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective Frontiers in Drug Safety and Regulation, 2022/12/23. Salvatore Crisafulli, Elisabetta Poluzzi, Carlotta Lunghi, Vincenzo Di Francesco, Luca Pellizzari, Luca Pasina, Chiara Elli, Francesco Trotta, Agnese Cangini, Caterina Trevisan, Maria Beatrice Zazzara, Graziano Onder, Gianluca Trifirò. DOI 10.3389/fdsfr.2022.1011701

Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People Pharmaceuticals, 2022/08. Carlotta Lunghi, Caterina Trevisan, Michele Fusaroli, Valentina Giunchi, Emanuel Raschi, Elisa Sangiorgi, Marco Domenicali, Stefano Volpato, Fabrizio De Ponti, ELISABETTA POLUZZI. DOI 10.3390/ph15080977

Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian. Canadian journal on aging = La revue canadienne du vieillissement, 2022/05. Guénette L, Turcotte V, Bélanger L, Blais L, Sirois C, Lunghi C, Duncan P. DOI 10.1017/s0714980822000058

Global prevalence of antidepressant utilization in the community: A protocol for a systematic review 2022/02. Lunghi C, Dugas M, Leclerc J, Poluzzi E, Martineau C, Carnovale V, Stéfan T, Blouin P, Lépine J, Jalbert L, Espinoza Suarez NR, Svyntozelska O, LeBlanc A. DOI 10.1101/2022.02.17.22271152

Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatment. Diabetes & metabolism, 2022/02. Tardif I, Guénette L, Zongo A, Demers É, Lunghi C. DOI 10.1016/j.diabet.2022.101334

What methods are used to study the association between medication adherence trajectories, estimated with the group-based trajectory modeling (GBTM) method, and health-related outcomes?—a protocol for a systematic review Systematic Reviews, 2022. Memoli, V., Ekanmian, G., Lunghi, C., Bouhnik, A.-D., Lauzier, S., Guénette, L.. DOI 10.1186/s13643-022-01971-y

What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System Drug Safety, 2022. Lunghi, C., Fusaroli, M., Giunchi, V., Raschi, E., Zongo, A., Poluzzi, E..

Risk of Psychotic Disorders Among Patients with Medical Cannabis Authorization: A Longitudinal Cohort Study Drug Safety, 2022. Lee, C., Lunghi, C., Eurich, D. T., Dyck, J. R. B., Hyshka, E., Hanlon, J. G., Zongo, A..

Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system Pharmacoepidemiology and Drug Safety, 2022. Giunchi, Valentina, Fusaroli, Michele, Lunghi, Carlotta, Zongo, Arsene, Raschi, Emanuel, Poluzzi, Elisabetta.

Patient and health system factors associated with potentially inappropriate opioid use in non-cancer community-dwelling older adults Pharmacoepidemiology and Drug Safety, 2022. D'Aiuto, Carina, Lunghi, Carlotta, Guenette, Line, Berbiche, Djamal, Bertrand, Karine, Vasiliadis, Helen-Maria.

Medication use in the year before and after a diagnosis of cluster B personality disorder: Trends and patterns between 2002 and 2018 in Quebec, Canada Pharmacoepidemiology and Drug Safety, 2022. Lunghi, Carlotta, Cailhol, Lionel, Massamba, Victoria, Sidi, Elhadji Anassou Laouan, Sirois, Caroline, Rahme, Elham, Rochette, Louis, Renaud, Suzane, Villeneuve, Evens, Koch, Marion, Biskin, Robert, David, Pierre, Martineau, Cathy, Lesage, Alain.

Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review BMJ Open, 2022. Lunghi, C., Dugas, M., Leclerc, J., Poluzzi, E., Martineau, C., Carnovale, V., Stéfan, T., Blouin, P., Lépine, J., Jalbert, L., Espinoza Suarez, N.R., Svyntozelska, O., Dery, M.-P., Ekanmian, G., Nogueira, D.M., Akinola, P.S., Turcotte, S., Skidmore, B., Leblanc, A.. DOI 10.1136/bmjopen-2022-062197

Factors associated with potentially inappropriate opioid use in community-living older adults consulting in primary care International Journal of Geriatric Psychiatry, 2022. D’Aiuto, C., Lunghi, C., Guénette, L., Berbiche, D., Pitrou, I., Bertrand, K., Vasiliadis, H.-M.. DOI 10.1002/gps.5780

Definition and validation of case detection algorithms using Quebec medico-administrative databases (med-echo and ramq) for depression among seniors Pharmacoepidemiology and Drug Safety, 2022. Ekanmian, Giraud, Lunghi, Carlotta, Vasiliadis, Helen-Maria, Guenette, Line.

Comorbidity, trauma, and mortality in children and young adults using ADHD medications in Quebec between 2000 and 2020 Pharmacoepidemiology and Drug Safety, 2022. Lunghi, Carlotta, Vasiliadis, Helen-Maria, Rahme, Elham, Rochette, Louis, Gignac, Martin, Massamba, Victoria, Diallo, Fatoumata Binta, Fansi, Alvine, Cortese, Samuele, Lesage, Alain.

ADHD Medication Use and Psychiatric Comorbidity, Trauma and Mortality in Children and Young Adults: A Cohort Study from Quebec, Canada Drug Safety, 2022. Lunghi, C., Vasiliadis, H. M., Rahme, E., Rochette, L., Gignac, M., Massamba, V., Diallo, F. B., Fansi, A., Cortese, S., Lesage, A..

Morbidities and mortality of diagnosed attention deficit hyperactivity disorder (ADHD) over the youth lifespan: A population-based retrospective cohort study. International journal of methods in psychiatric research, 2021/12. Diallo FB, Pelletier É, Vasiliadis HM, Rochette L, Vincent A, Palardy S, Lunghi C, Gignac M, Lesage A. DOI 10.1002/mpr.1903

Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada Pharmacoepidemiology and Drug Safety, 2021/11/08. DOI 10.1002/pds.5383

Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study. Acta diabetologica, 2021/09. Messina R, Iommi M, Rucci P, Reno C, Fantini MP, Lunghi C, Altini M, Bravi F, Rosa S, Nicolucci A, Di Bartolo P. DOI 10.1007/s00592-021-01791-x

Utilization of Health Care Services by Patients With Cluster B Personality Disorders or Schizophrenia. Psychiatric services (Washington, D.C.), 2021/07. Cailhol L, Pelletier É, Rochette L, Renaud S, Koch M, David P, Villeneuve E, Lunghi C, Lesage A. DOI 10.1176/appi.ps.202000554

Group-Based Trajectory Modelling (GBTM) To Assess the Effect of Medication Adherence on Health-Related Outcomes: A Protocol for A Systematic Review 2021/06. Memoli V, Ekanmian G, Lunghi C, Bouhnik A, Lauzier S, Guénette L. DOI 10.21203/rs.3.rs-565670/v1

Economic Evaluations of Interventions to Optimize Medication Use in Older Adults with Polypharmacy and Multimorbidity: A Systematic Review Clinical Interventions in Aging, 2021/05/05. DOI 10.2147/cia.s304074

Group-Based Trajectory Modelling (GBTM) To Assess the Effect of Medication Adherence on Health-Related Outcomes: A Protocol for A Systematic Review ResearchSquare, 2021. Memoli, V., Ekanmian, G., Lunghi, C., Bouhnik, A.-D., Lauzier, S., Guénette, L.. DOI 10.21203/rs.3.rs-565670

Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes International Journal of Clinical Pharmacy, 2021. Lunghi, Carlotta, Zongo, Arsene, Tardif, Isabelle, Demers, Eric, Diendere, Joel D. R., Guenette, Line.

Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes: A nested case-control study. Diabetes research and clinical practice, 2020/11/30. DOI 10.1016/j.diabres.2020.108566

Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study Neuropsychiatric Disease and Treatment, 2020/05/07. DOI 10.2147/ndt.s241780

Trends of polypharmacy among older adults with schizophrenia in Quebec, Canada between 2000 and 2017 European Journal of Public Health, 2020. Lunghi, C., Rochette, L., Ouali, A., Sirois, C.. DOI 10.1093/EURPUB/CKAA165.822

Benefits, risks and impacts on quality of life of medications used in multimorbid older adults: a Delphi study International Journal of Clinical Pharmacy, 2020. Sirois, C., Lunghi, C., Berthelot, W., Laroche, M.-L., Frini, A.. DOI 10.1007/s11096-019-00935-y

Exposure to guideline‐recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter? Pharmacoepidemiology and Drug Safety, 2019/12/03. DOI 10.1002/pds.4915

Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health. Pharmacy (Basel, Switzerland), 2019/08/29. DOI 10.3390/pharmacy7030126

LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS Value in Health, 2019. Lunghi, C., Antonazzo, I. C., Poluzzi, E., Burato, S., Raschi, E., Forcesi, E., Sangiorgi, E., Menchetti, M., Roberge, P.. DOI 10.1016/J.JVAL.2019.04.1079